Royce & Associates’s Genesco GCO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-5,898
| Closed | -$271K | – | 927 |
|
|
2022
Q4 | $271K | Sell |
5,898
-5,989
| -50% | -$272K | ﹤0.01% | 870 |
|
|
2022
Q3 | $467K | Sell |
11,887
-8,951
| -43% | -$478K | 0.01% | 826 |
|
|
2022
Q2 | $1.04M | Sell |
20,838
-1,991
| -9% | -$119K | 0.01% | 745 |
|
|
2022
Q1 | $1.45M | Buy |
22,829
+7,406
| +48% | +$482K | 0.01% | 763 |
|
|
2021
Q4 | $990K | Buy |
15,423
+3,648
| +31% | +$232K | 0.01% | 806 |
|
|
2021
Q3 | $680K | Buy |
11,775
+7,363
| +167% | +$438K | 0.01% | 864 |
|
|
2021
Q2 | $281K | Hold |
4,412
| – | – | ﹤0.01% | 969 |
|
|
2021
Q1 | $210K | Buy |
+4,412
| New | +$190K | ﹤0.01% | 998 |
|
|
2020
Q3 | – | Sell |
-4,412
| Closed | -$96K | – | 1058 |
|
|
2020
Q2 | $96K | Buy |
+4,412
| New | +$81.4K | ﹤0.01% | 981 |
|
|
2018
Q4 | – | Sell |
-217,591
| Closed | -$10.2M | – | 1169 |
|
|
2018
Q3 | $10.2M | Buy |
217,591
+114,940
| +112% | +$5.02M | 0.07% | 394 |
|
|
2018
Q2 | $4.08M | Sell |
102,651
-104,300
| -50% | -$4.44M | 0.03% | 650 |
|
|
2018
Q1 | $8.4M | Sell |
206,951
-135,500
| -40% | -$5.03M | 0.06% | 429 |
|
|
2017
Q4 | $11.1M | Buy |
+342,451
| New | +$9.41M | 0.07% | 363 |
|
|
2017
Q2 | – | Sell |
-659,510
| Closed | -$36.6M | – | 1123 |
|
|
2017
Q1 | $36.6M | Buy |
659,510
+7,500
| +1% | +$447K | 0.24% | 109 |
|
|
2016
Q4 | $40.5M | Sell |
652,010
-326,007
| -33% | -$19.9M | 0.26% | 109 |
|
|
2016
Q3 | $53.3M | Buy |
978,017
+129,578
| +15% | +$8.18M | 0.35% | 66 |
|
|
2016
Q2 | $54.6M | Buy |
848,439
+87,085
| +11% | +$5.76M | 0.36% | 59 |
|
|
2016
Q1 | $55M | Sell |
761,354
-494,871
| -39% | -$31.9M | 0.35% | 66 |
|
|
2015
Q4 | $71.4M | Sell |
1,256,225
-268,817
| -18% | -$15.5M | 0.43% | 47 |
|
|
2015
Q3 | $87M | Sell |
1,525,042
-523,073
| -26% | -$32.5M | 0.46% | 39 |
|
|
2015
Q2 | $135M | Buy |
2,048,115
+18,910
| +0.9% | +$1.3M | 0.57% | 22 |
|
|
2015
Q1 | $145M | Buy |
2,029,205
+5,455
| +0.3% | +$396K | 0.55% | 29 |
|
|
2014
Q4 | $155M | Sell |
2,023,750
-142,257
| -7% | -$10.8M | 0.54% | 29 |
|
|
2014
Q3 | $162M | Sell |
2,166,007
-61,531
| -3% | -$4.91M | 0.55% | 26 |
|
|
2014
Q2 | $183M | Buy |
2,227,538
+3,313
| +0.1% | +$253K | 0.54% | 27 |
|
|
2014
Q1 | $166M | Buy |
2,224,225
+638,296
| +40% | +$46.4M | 0.49% | 35 |
|
|
2013
Q4 | $116M | Buy |
1,585,929
+1,313,800
| +483% | +$91.8M | 0.33% | 75 |
|
|
2013
Q3 | $17.8M | Buy |
+272,129
| New | +$18.6M | 0.05% | 422 |
|
Other funds holding GCO
LPAM
Royce & Associates's GCO Position: Q1 2023 in Review
Royce & Associates sold out of Genesco (GCO) in Q1 2023, closing a stake of 5,898 shares — an estimated $271K sold.
Royce & Associates first reported a position in GCO in Q3 2013 and held it in 28 quarters. The position peaked at $183M in Q2 2014. 148 funds tracked by Wall St. Rank hold GCO as of Q1 2023.
- Royce & Associates reported no remaining Genesco position as of Q1 2023 after selling out during the quarter.
- Royce & Associates sold 5,898 Genesco shares in Q1 2023, an estimated $271K.
- Royce & Associates first reported a position in Genesco in Q3 2013 and held it in 28 quarters.
- Royce & Associates's Genesco position peaked at $183M in Q2 2014.
- 148 funds tracked by Wall St. Rank held Genesco as of Q1 2023.
Based on Royce & Associates's 13F filing for Q1 2023, filed 4 May 2023.